RN Mobile Menu


Rheumatology Network

The RA Revolution is Incomplete

Progress in RA research has stalled in the last 10 years, say two Lasker Award winners. "It is clear that the revolution is incomplete. As a medical community, we need to pick up the challenge again and get the job completed. Do we have the ambition and the will?"    (©PHOTOCREOShuttersstock.com)

Recent Content


Tuberculosis infections are the most common opportunistic infection in rheumatoid arthritis patients treated with tofacitinib.


Anti-CarP antibodies associated with increased disability and higher disease activity in patients with inflammatory polyarthritis.


Psoriatic arthritis is associated with an additional increase in cardiovascular disease. One hypothesis shows that rheumatic diseases and atherosclerosis may be related due to an inflammatory mechanism.


Two studies published in leading medical journals show that secukinumab, a human monoclonal antibody used to treat psoriasis, could work in psoriatic arthritis.


Repetitive intraarticular corticosteroid injections to the temporomandibular joint do not prevent progressive osseous deformation nor normalize mandibular growth in children with juvenile idiopathic arthritis.


New methodologies for clinical trials in lupus are in development. If successful, the next decade could see the development of new targeted therapies for lupus.


Teens and young adults with systemic lupus erythematosus view the disease as constraining their choices and forcing them to make sacrifices, new research finds.

By clicking Accept, you agree to become a member of the UBM Medica Community.